Accelerate Diagnosti (AXDX)

Mar 21, 2025, 1:52 PM EDT - 5 weeks ago

Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance

Mar 21, 2025, 8:30 AM EDT - 5 weeks ago

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results

Jan 10, 2025, 4:05 PM EST - 3 months ago

Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results

Nov 8, 2024, 11:58 PM EST - 6 months ago

Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 6 months ago

Accelerate Diagnostics Reports Third Quarter 2024 Financial Results

Oct 25, 2024, 4:30 PM EDT - 6 months ago

Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results

Sep 30, 2024, 9:15 AM EDT - 7 months ago

Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System

Aug 10, 2024, 6:55 PM EDT - 9 months ago

Accelerate Diagnostics, Inc. (AXDX) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 9 months ago

Accelerate Diagnostics Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 4:00 PM EDT - 9 months ago

Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial

Aug 8, 2024, 11:09 AM EDT - 9 months ago

Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results

May 8, 2024, 7:50 PM EDT - 1 year ago

Accelerate Diagnostics, Inc. (AXDX) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:42 PM EDT - 1 year ago

Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results

May 2, 2024, 9:30 AM EDT - 1 year ago

Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.

Mar 28, 2024, 7:50 PM EDT - 1 year ago

Accelerate Diagnostics Inc. (AXDX) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 4:05 PM EDT - 1 year ago

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results

Mar 7, 2024, 9:30 AM EST - 1 year ago

Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.

Jan 19, 2024, 9:20 AM EST - 1 year ago

Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement

Jan 16, 2024, 7:45 AM EST - 1 year ago

Accelerate Diagnostics Announces Launch of Proposed Public Offering

Jan 7, 2024, 8:00 PM EST - 1 year ago

Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results

Nov 27, 2023, 9:15 AM EST - 1 year ago

Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®

BRKR

Nov 9, 2023, 5:37 PM EST - 1 year ago

Accelerate Diagnostics, Inc. (AXDX) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:05 PM EST - 1 year ago

Accelerate Diagnostics Reports Third Quarter 2023 Results

Oct 30, 2023, 9:30 AM EDT - 1 year ago

Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.

Aug 10, 2023, 8:12 PM EDT - 1 year ago

Accelerate Diagnostics, Inc. (AXDX) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 4:05 PM EDT - 1 year ago

Accelerate Diagnostics Reports Second Quarter 2023 Financial Results

Jul 27, 2023, 9:30 AM EDT - 1 year ago

Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results

Jul 10, 2023, 9:00 AM EDT - 1 year ago

Accelerate Diagnostics Announces 1-for-10 Reverse Stock Split

Jun 13, 2023, 9:00 AM EDT - 2 years ago

Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform Wave

May 11, 2023, 10:36 PM EDT - 2 years ago

Accelerate Diagnostics, Inc. (AXDX) Q1 2023 Earnings Call Transcript

May 11, 2023, 4:05 PM EDT - 2 years ago

Accelerate Diagnostics Reports First Quarter 2023 Financial Results

Apr 27, 2023, 9:30 AM EDT - 2 years ago

Accelerate Diagnostics scheduled call to review 2023 first quarter results

Mar 29, 2023, 10:22 PM EDT - 2 years ago

Accelerate Diagnostics, Inc. (AXDX) Q4 2022 Earnings Call Transcript

Mar 29, 2023, 4:05 PM EDT - 2 years ago

Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 15, 2023, 9:30 AM EDT - 2 years ago

Accelerate Diagnostics scheduled call to review 2022 fourth quarter and full year results

Mar 14, 2023, 8:33 PM EDT - 2 years ago

Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement

Mar 8, 2023, 8:30 AM EST - 2 years ago

Accelerate Diagnostics announces appointment of Hany Massarany to Chairman of Board of Directors

Dec 19, 2022, 1:32 PM EST - 2 years ago

Accelerate Diagnostics submits 510(K) application to FDA for Gram-negative menu expansion and breakpoint updates for the Accelerate PhenoTest® BC kit

Nov 14, 2022, 9:11 PM EST - 2 years ago

Accelerate Diagnostics, Inc. (AXDX) Q3 2022 Earnings Call Transcript

Nov 14, 2022, 4:05 PM EST - 2 years ago

Accelerate Diagnostics Reports Third Quarter 2022 Financial Results

Oct 27, 2022, 1:00 PM EDT - 2 years ago

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Accelerate Diagnostics, Inc. (AXDX) on Behalf of Investors

Oct 26, 2022, 2:52 PM EDT - 2 years ago

The Law Offices of Frank R. Cruz Announces Investigation of Accelerate Diagnostics, Inc. (AXDX) on Behalf of Investors

Oct 26, 2022, 8:56 AM EDT - 2 years ago

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Accelerate Diagnostics, Inc. and Encourages Investors with Losses to Contact the Firm

Oct 25, 2022, 9:59 AM EDT - 2 years ago

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Accelerate Diagnostics, Inc. and Encourages Investors with Losses to Contact the Firm